Compare · DASH vs GDRX
DASH vs GDRX
Side-by-side comparison of DoorDash Inc. (DASH) and GoodRx Holdings Inc. (GDRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DASH and GDRX operate in EDP Services (Technology), so they compete in similar markets.
- DASH is the larger of the two at $35.57B, about 30.1x GDRX ($1.18B).
- Over the past year, DASH is down 7.6% and GDRX is down 19.1% - DASH leads by 11.5 points.
- DASH has been more active in the news (24 items in the past 4 weeks vs 8 for GDRX).
- Both have 25 recent analyst ratings on file.
- Company
- DoorDash Inc.
- GoodRx Holdings Inc.
- Price
- $225.58-2.66%
- $3.48-0.71%
- Market cap
- $35.57B
- $1.18B
- 1M return
- +12.51%
- +9.97%
- 1Y return
- -7.57%
- -19.09%
- Industry
- EDP Services
- EDP Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 24
- 8
- Recent ratings
- 25
- 25
DoorDash Inc.
DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and dashers in the United States and internationally. It operates DoorDash marketplace, which provides an array of services that enable merchants to solve mission-critical challenges, such as customer acquisition, delivery, insights and analytics, merchandising, payment processing, and customer support; and offers DoorDash Drive, a white-label logistics service; DoorDash Storefront that enables merchants to offer consumers on-demand access to e-commerce. The company was formerly known as Palo Alto Delivery Inc. and changed its name to DoorDash, Inc. in 2015. DoorDash, Inc. was founded in 2013 and is headquartered in San Francisco, California.
GoodRx Holdings Inc.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Latest DASH
- Rosenblatt initiated coverage on DoorDash with a new price target
- PRESIDENT AND COO Adarkar Prabir sold $12,813,899 worth of shares (55,289 units at $231.76) as part of a pre-agreed trading plan and exercised 43,550 shares at a strike of $7.16, decreasing direct ownership by 1% to 930,211 units (SEC Form 4)
- SEC Form DEF 14C filed by DoorDash Inc.
- CHIEF EXECUTIVE OFFICER Xu Tony sold $7,666,938 worth of shares (33,334 units at $230.00) as part of a pre-agreed trading plan and exercised 33,334 shares at a strike of $7.16 (SEC Form 4)
- GENERAL COUNSEL AND SECRETARY Sherringham Tia sold $515,607 worth of shares (2,265 units at $227.64) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 118,262 units (SEC Form 4)
- CHIEF ACCOUNTING OFFICER Lee Gordon S sold $489,354 worth of shares (2,204 units at $222.03) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 84,332 units (SEC Form 4)
- Director Tang Stanley acquired 10,134 shares as part of a pre-agreed trading plan and sold $2,280,150 worth of shares (10,134 units at $225.00) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by DoorDash Inc.
- PRESIDENT AND COO Adarkar Prabir sold $3,778,407 worth of shares (17,126 units at $220.62), decreasing direct ownership by 2% to 941,950 units (SEC Form 4) to cover taxes
- CHIEF ACCOUNTING OFFICER Lee Gordon S sold $642,236 worth of shares (2,911 units at $220.62), decreasing direct ownership by 3% to 86,536 units (SEC Form 4) to satisfy withholding obligation
Latest GDRX
- Amendment: SEC Form SCHEDULE 13D/A filed by GoodRx Holdings Inc.
- Large owner Francisco Partners Iv, L.P. sold $5,477,482 worth of shares (1,567,044 units at $3.50) (SEC Form 4)
- Large owner Francisco Partners Iv, L.P. converted options into 7,500,000 shares, disposed of 4,739,005 shares and sold $4,201,230 worth of shares (1,193,951 units at $3.52) (SEC Form 4)
- SEC Form 144 filed by GoodRx Holdings Inc.
- Chief Accounting Officer Chan Thomas (Tc) converted options into 10,115 shares and covered exercise/tax liability with 5,149 shares, increasing direct ownership by 58% to 13,546 units (SEC Form 4)
- Officer Fengler Justin converted options into 48,532 shares and covered exercise/tax liability with 21,407 shares, increasing direct ownership by 115% to 50,776 units (SEC Form 4)
- SEC Form 4 filed by Officer Fengler Justin
- New insider Fengler Justin claimed ownership of 23,651 shares (SEC Form 3)
- GoodRx Holdings Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by GoodRx Holdings Inc.